I'm LongbridgeAI, I can summarize articles.Xylem Inc reported record Q2 EPS of $1.46 and expanded margins, driven by strong backlog and major contract wins, including a historic Dow deal. However, near-term revenue growth is dampened by weakness in China, delays in electric metering projects, and portfolio pruning. Management raised full-year EPS guidance to $5.55–$5.70 but narrowed organic revenue outlook to 2%–3%, citing macro headwinds despite robust cash generation and strategic M&A activity.
Xylem Inc ((XYL)) has held its Q2 earnings call. Read on for the main highlights of the call.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Xylem Inc’s latest earnings call painted a picture of a company powering ahead on profitability even as revenue growth cools. Management highlighted record earnings, expanding margins, strong cash generation and major long‑term contract wins. At the same time, weakness in China, delays in electric metering projects and deliberate portfolio pruning are dampening near‑term sales momentum, leading to a tighter revenue outlook.
Record EPS and Margin Expansion
Xylem reported record GAAP EPS of $1.46 for the quarter, a 16% increase from last year. Adjusted EBITDA margin reached 23.3%, improving 150 basis points year‑on‑year, and management raised full‑year margin guidance to 23.1%–23.5%, signaling continued focus on pricing, mix and productivity.
Strong Backlog and Orders Momentum
The company exited the quarter with a hefty $5.3 billion backlog and a book‑to‑bill ratio well above 1. Overall orders surged 41% versus the prior year, with growth in three of four segments, giving investors solid visibility into revenue over both the near and longer term.
Major Contract Wins and Outsourced Water Growth
Xylem secured the largest contract in its history with a major Dow order and landed an approximately $850 million outsourced water project spanning 23 years. Its Water Solutions & Services business posted strong orders growth, while segment EBITDA margin expanded to 25.3%, up 90 basis points from a year ago.
Applied Water and Data Center Acceleration
Applied Water orders climbed 9%, with book‑to‑bill comfortably above 1, despite some short‑cycle and residential softness. Data center demand was the standout, with orders up more than 300% in the quarter and management expecting data‑center‑related revenue to rise about 200% this year and reach roughly 2% of total sales by year‑end.
Water Infrastructure Margin Outperformance
Water Infrastructure revenue increased a modest 3%, but profitability was a bright spot. Segment EBITDA margin expanded by about 480 basis points, driven by a better mix, pricing discipline, productivity gains and strong transport growth in North America.
Disciplined Capital Allocation and Balance Sheet
Net debt to adjusted EBITDA stands at 0.8x even after opportunistic share repurchases, leaving ample financial flexibility. Management reiterated its target of a low‑double‑digit free cash flow margin for the year and pointed to robust cash generation in the first half.
Strategic M&A and Portfolio Actions
The company continued to reshape its portfolio with the TriOS acquisition to bolster sensing and water‑quality intelligence and a signed deal for WaterFleet, adding mobile treatment and recurring services. Xylem is targeting about $1 billion of M&A capacity and has already executed more than $400 million in divestitures to sharpen strategic focus.
Raised EPS Guidance, Narrowed Revenue Range
Management lifted full‑year EPS guidance to $5.55–$5.70 from $5.35–$5.60, reflecting margin strength and disciplined execution. At the same time, the organic revenue outlook was narrowed to 2%–3%, with reported sales expected around $9.2 billion, as near‑term macro and portfolio headwinds temper the top line.
Significant China Weakness
China remains a notable drag, with overall revenue from the country down about 27% and Water Infrastructure sales there off roughly 40%. This slump is creating around a 1% headwind to total company revenue versus last year and is weighing on both orders and segment performance.
MCS Near‑term Slowdown
In Measurement & Control Solutions, book‑to‑bill slipped below 1 and backlog held near $1.2 billion. Orders grew a modest 2% while revenue declined 1%, and segment EBITDA margin fell 200 basis points to 21.1%, prompting a lower full‑year outlook as electric metering projects are pushed out.
80/20 Walkaway Revenue Drag
Xylem’s ongoing 80/20 portfolio simplification is trimming low‑value business and lifting margins but at a short‑term cost to sales. These actions led to nearly 2% “walkaway” revenue this quarter, temporarily depressing organic growth while improving the company’s long‑run competitive positioning.
Modest Overall Revenue Growth
Reported revenue in the quarter rose just 1% year‑over‑year, underscoring the impact of metering delays, China weakness and walkaway decisions. Reflecting these pressures, management narrowed full‑year organic revenue guidance to a 2%–3% increase, signaling a more measured growth profile near term.
Segment Order Disparities
Order trends were uneven beneath the surface, with Water Infrastructure orders down 4% in the quarter and MCS hampered by metering project delays. Meanwhile, some short‑cycle pump and valve exposure and softness in small residential markets constrained upside in Applied Water despite its healthy overall order growth.
Share Repurchase Impact on Leverage
The company used its balance sheet to return capital through opportunistic share buybacks, nudging net debt‑to‑adjusted‑EBITDA up to 0.8x. While leverage rose from prior levels, management emphasized that the overall balance sheet remains conservative and supportive of further strategic investment.
Near‑term Uncertainties
Executives flagged several risks that could delay projects, including election‑related capital caution, affordability concerns around electric meter deployments and shifting economic conditions in China. These uncertainties reinforce the company’s conservative stance on revenue guidance despite strong underlying demand drivers.
Forward‑Looking Guidance and Outlook
For the full year, Xylem now expects about $9.2 billion in reported revenue, up roughly 2%, with organic growth of 2%–3% and adjusted EBITDA margin between 23.1% and 23.5%. Third‑quarter guidance calls for flat reported revenue with about 3% organic growth, EBITDA margin of 23.5%–24% and EPS of $1.42–$1.47, while the company maintains its low‑double‑digit free cash flow margin target and sees no material impact from recent tariffs.
Xylem’s earnings call showed a business leaning on margin strength, cash generation and strategic wins to offset a slower revenue trajectory. For investors, the story is one of solid profitability, rising exposure to attractive markets such as data centers and outsourced water, and manageable macro headwinds, suggesting resilience even in a more cautious demand environment.
